UNDERGRADUATE EDUCATION ABOUT CANCER - A SURVEY OF CLINICAL ONCOLOGISTS AND CLINICIAN RESPONSIBLE FOR CANCER TEACHING IN AUSTRALIAN MEDICAL-SCHOOLS

被引:16
|
作者
TATTERSALL, MHN
LANGLANDS, AO
SMITH, W
IRWIG, L
机构
[1] Department of Cancer Medicine, University of Sydney, NSW 2006, Blackburn Building
关键词
D O I
10.1016/0959-8049(93)90314-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Undergraduate cancer education in Australian medical schools is not integrated and there is little evidence of change in content or structure in recent years in spite of major changes in knowledge about cancer epidemiology and cancer biology, and in cancer management. A recent survey of graduating students/interns from all Australian medical schools revealed a disturbing variability in experience and lack of important knowledge. There was evidence of substantial differences in knowledge of, and rating of teaching between the different disciplines involved in cancer control and cancer management. To examine possible reasons for this, we surveyed cancer clinicians and teachers of oncology in the undergraduate curriculum at Australian medical schools. We asked them the same questions of knowledge as the students, and also to comment on the type and emphasis of teaching desirable in the medical students' cancer curriculum. The results indicate not only that the survey instrument was seen to be relevant, but also that some of the bias and misinformation detected in the student experiences may be attributed to attitude, knowledge and differences of opinion of the teachers. The results highlight the need for an integrated cancer curriculum to inform graduates about an illness which will be diagnosed in more than a quarter of the Australian population.
引用
收藏
页码:1639 / 1642
页数:4
相关论文
共 34 条
  • [21] ONCOLOGISTS' BELIEFS ABOUT MEDICAL MARIJUANA'S EFFECTIVENESS FOR SLEEP IN CANCER PATIENTS: A NATIONALLY REPRESENTATIVE SURVEY
    Zhou, E. S.
    Nayak, M. M.
    Braun, I. M.
    SLEEP, 2020, 43 : A389 - A389
  • [22] What Do Oncologists Think Patients with Incurable Cancer Should Be Told about Their Prognosis? A Survey of Medical Oncologists in Australia and New Zealand
    Vasista, A.
    Stockler, M.
    Martin, A.
    Lawrence, N.
    Kiely, B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 49 - 49
  • [23] What should doctors know about cancer? Undergraduate medical education from a societal perspective
    Barton, Michael B.
    Bell, Pamela
    Sabesan, Sabe
    Koczwara, Bogda
    LANCET ONCOLOGY, 2006, 7 (07): : 596 - 601
  • [24] What do oncologists think patients with incurable cancer should be told about their prognosis? A survey of medical oncologists in Australia and New Zealand.
    Vasista, Anuradha
    Stockler, Martin R.
    Martin, Andrew James
    Lawrence, Nicola Jane
    Kiely, Belinda E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Australian Non-Small Cell Lung Cancer (NSCLC) Biomarker Testing Practices - A Survey of Medical Oncologists and Pathologists
    Gard, G.
    Kao, S.
    Solomon, B.
    Pavlakis, N.
    Cooper, W.
    Millward, M.
    Roberts-Thomson, R.
    Nott, L.
    Hughes, B.
    Hong, W.
    Dumas, M.
    Ramanujam, S.
    Wang, A.
    Elkouly, E.
    Gibbs, P.
    Markman, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S587 - S587
  • [27] A Thorough Analysis of the Current State of Cancer Education in Medical Schools and Application of Experimental Teaching Techniques and Their Efficacy
    Klufas, Andrew
    Shin, Grace
    Raphael, Ryan
    Sarfaty, Suzanne C.
    Hirsch, Ariel E.
    ADVANCES IN MEDICAL EDUCATION AND PRACTICE, 2020, 11 : 931 - 946
  • [28] How are cared surviving cancer patients? Results of an Italian national survey to medical oncologists (MO) about clinical and organizational features of follow-up (FU)
    Numico, Gianmauro
    Pinto, Carmine
    Ucci, Giovanni
    Gori, Stefania
    Di Maio, Massimo
    Cancian, Maurizio
    De Lorenzo, Francesco
    Venturini, Marco
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] A SURVEY OF AUSTRALIAN MEDICAL ONCOLOGISTS REGARDING THE USE OF MICROSATELLITE INSTABILITY (MSI) WHEN MAKING RECOMMENDATIONS ABOUT ADJUVANT CHEMOTHERAPY (AC) FOR PEOPLE WITH RESECTED EARLY STAGE COLON CANCER (ESCC)
    Loh, K.
    Michael, M.
    Zalcberg, J. R.
    Jefford, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 59 - 59